🇺🇸 FDA

Company profile · Sponsor

Targanta

Targanta Netherlands B.V.

E008AF8 · EMA pharma EU
Pipeline
1
Drugs
0
Patents
0

Quick answer

Targanta (E008AF8) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E008AF8
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (1)

Search pipeline →

  1. oritavancin

    Targanta

    Staphylococcal Skin Infections

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is Targanta?

Targanta (E008AF8) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Targanta sponsor?

We track 1 ClinicalTrials.gov-linked program for Targanta, including oritavancin. Open each program for phase, modality, NCT IDs, and indication details.

Where does Targanta company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.